NGS-based AMR Detection Market to Reach USD 1.67 Billion by 2035, Driven by Technological Advancements and Global AMR Threat

The global NGS-based Antimicrobial Resistance (AMR) Detection Market is projected to experience significant expansion over the next decade. Estimated at USD 823.7 million in 2025, the market is expected to nearly double, reaching USD 1.67 billion by 2035. This robust growth, driven by a 7.3% compound annual growth rate (CAGR), is attributed to the growing global concern over antimicrobial resistance, advancements in Next-Generation Sequencing (NGS) technologies, and increasing demand for rapid, accurate diagnostics in clinical and public health settings.

Unlock detailed analytics - Request your personalized report now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-23939

Market Dynamics: Fueling Growth

The rising incidence of antimicrobial resistance (AMR) worldwide is a critical driver for this market's expansion. According to the World Health Organization (WHO), AMR is already responsible for millions of deaths each year, and projections indicate that by 2050, it could lead to more fatalities than cancer. To counter this growing threat, there is a clear shift towards genomic technologies for detecting AMR profiles in pathogens, making NGS the tool of choice for many healthcare systems globally.

NGS technology, particularly Whole-Genome Sequencing (WGS), offers a level of detailed analysis far superior to traditional culture-based diagnostic methods. This has accelerated its adoption in hospitals, public health labs, and pharmaceutical companies. NGS platforms are being integrated into routine diagnostic workflows, enabling the precise identification of resistance genes and antimicrobial susceptibility patterns, all of which play a pivotal role in antibiotic stewardship programs.

Technological Advancements and Product Trends

In 2025, instruments and platforms will dominate the NGS-based AMR detection market, accounting for over 56% of the total market share. These high-throughput sequencing systems, essential for comprehensive AMR profiling, are driving the market as healthcare providers prioritize speed and scalability in their diagnostic solutions. NGS platforms are evolving with enhanced accuracy, faster processing times, and improved multiplexing capabilities, leading to greater efficiency and widespread adoption.

Additionally, reagents and consumables, such as sequencing kits and sample preparation materials, are also anticipated to see steady growth. These products are essential to maintaining the workflow of NGS systems and are expected to account for a significant portion of the market share by 2030.

While bioinformatics & software solutions currently represent a smaller segment (15.8% market share in 2025), their importance is growing as advancements in artificial intelligence (AI) and cloud-based analytics revolutionize how sequencing data is processed and interpreted. AI-powered tools are streamlining data analysis, reducing human error, and enabling faster, more reliable AMR detection.

Regional Growth: Key Markets and Expansion

Regionally, Asia Pacific is set to become the fastest-growing region in the global NGS-based AMR detection market, with countries like China and India leading the charge. Both nations are experiencing rapid improvements in genomics infrastructure, bolstered by government-backed initiatives aimed at combating AMR. India, in particular, is projected to grow at a CAGR of 7.8% due to the expansion of tertiary care hospitals and the increasing availability of sequencing technologies.

In North America, the market will continue to be driven by the United States, where federal initiatives such as the CDC's Antibiotic Resistance Solutions Initiative and the National Action Plan for Combating Antibiotic-Resistant Bacteria are accelerating the adoption of NGS for AMR surveillance. By 2035, the U.S. market is expected to reach USD 819.5 million, with hospitals, public health labs, and pharmaceutical companies being the major end users.

Europe, especially countries like Germany, France, and the UK, will maintain strong market shares in the coming years. Germany, with a projected CAGR of 7.6%, will lead the European market, benefiting from government funding in public health genomics and enhanced infrastructure for AMR surveillance.

Competitive Landscape: Industry Leaders

The competitive landscape of the NGS-based AMR detection market is moderately consolidated, with key players like Illumina, Thermo Fisher Scientific, and QIAGEN holding substantial market shares. Illumina, the market leader, is projected to capture over 31% of the market in 2025, bolstered by its NextSeq and MiSeq sequencing platforms, which are widely adopted in hospitals and clinical laboratories.

Other notable players include bioMérieux, which is enhancing its AMR portfolio through strategic acquisitions, and emerging companies like CD Genomics, which offer cost-effective sequencing services and customizable AMR panels. The continued emphasis on collaboration between industry leaders and public health organizations is crucial to improving global AMR surveillance and diagnostics.

Get Full Access of this Report:
https://www.futuremarketinsights.com/reports/ngs-based-amr-detection-market

Explore Related Research Reports on Healthcare Domain

Rabies Diagnostics Market:
https://www.futuremarketinsights.com/reports/rabies-diagnostics-market

Pre-Pregnancy Genetic Testing Market:
https://www.futuremarketinsights.com/reports/pre-pregnancy-genetic-testing-market

Liquid Chromatography Systems Market:
https://www.futuremarketinsights.com/reports/liquid-chromatography-systems-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.